FILTER CONTENT

Filters
Company Names

Research

  • 7investing logo next to the Avita Medical logo.
    By Published On: February 17, 2025

    AVITA Medical: 2025 Will Be an “Inflection Point Year”

    AVITA Medical is continuing to show signs of progress. Its recently-reported fourth quarter [...]

  • By Published On: September 19, 2024

    September 2024 Conviction Rating Review

  • By Published On: August 26, 2024

    Here are 3 Key Risks at TransMedics. But the Stock is Still a Buy.

  • By Published On: December 18, 2023

    7investing’s 2023 Year in Review: An Updated Look at All of Our Stock Picks

  • By Published On: February 10, 2023

    Affirm Navigates a Turbulent Macro; Shares Still a “Buy”

  • By Published On: December 19, 2022

    7investing’s 2022 Year in Review: An Updated Look at All of Our Stock Picks

  • By Published On: November 22, 2022

    7investing Update: We Are Selling These 9 Stocks

  • 7investing logo next to the Spotify logo.
    By Published On: November 22, 2022

    Sell Spotify

  • 7investing logo next to the One Medical logo.
    By Published On: September 13, 2022

    Sell One Medical

  • an image of the 7investing logo
    By Published On: July 22, 2022

    7investing Company Update Roundup: July 2022

  • 7investing logo next to the One Medical logo.
    By Published On: July 21, 2022

    Amazon is Buying One Medical. Here’s What Investors Need to Know.

  • By Published On: June 9, 2022

    We’re Updating Several of Our Conviction Ratings

  • 7investing logo next to the One Medical logo.
    By Published On: May 22, 2022

    Staying Focused and Executing Well, One Medical Reports a Strong First Quarter

  • By Published On: May 16, 2022

    Affirm is a “Buy”; Extends Partnership With Shopify But Uncertainties Remain

  • A card that has the word update written on it being held up by a clothespin.
    By Published On: March 22, 2022

    7investing Company Update Roundup: March 2022

  • 7investing logo next to the One Medical logo.
    By Published On: March 7, 2022

    One Medical Beats FY2021 Guidance but Shares Continue to Take a Beating